Literature DB >> 18303419

Computed-tomography findings of emphysema: correlation with spirometric values.

Hisamitsu Omori1, Keisaku Fujimoto, Takahiko Katoh.   

Abstract

PURPOSE OF REVIEW: There is increasing interest in using multichannel computed-tomography scanning in the characterization of subjects with chronic obstructive pulmonary disease. Three distinct components - emphysema, large-airway inflammation and small-airway abnormality - have been evaluated using qualitative and quantitative approaches. Here we highlight computed-tomography findings of chronic obstructive pulmonary disease and correlation with spirometric values. RECENT
FINDINGS: A considerable percentage of the subjects with emphysema detected by computed-tomography screening had normal spirometry. Severity of emphysema varies widely, even with same disease stage in chronic obstructive pulmonary disease. Studies of the relationship between high-resolution computed-tomography lung-attenuation measurements acquired under spirometric control of inspiratory and expiratory lung volume and pulmonary function showed that inspiratory measurements assess the extent of emphysema and that expiratory measurements reflect airflow limitation and air trapping. The evaluation using three-dimensional computed tomography demonstrates that airflow limitation is more closely related to the dimensions of small airways than large airways.
SUMMARY: Volumetric computed-tomography scans allow diagnosis and quantification of the individual small airway and emphysema phenotypes present in people with chronic obstructive pulmonary disease. New computed-tomography scanning techniques should provide new insights into further understanding of the heterogeneity of chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  2008        PMID: 18303419     DOI: 10.1097/MCP.0b013e3282f3f18f

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  6 in total

1.  Respiratory Disability in The Van Region Based on the Medical Board Reports.

Authors:  Buket Mermit Çilingir
Journal:  Turk Thorac J       Date:  2016-04-01

2.  Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging.

Authors:  Jaideep Dhariwal; Rachel C Tennant; David M Hansell; John Westwick; Christoph Walker; Simon P Ward; Neil Pride; Peter J Barnes; Onn Min Kon; Trevor T Hansel
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

3.  Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.

Authors:  Michael T Borchers; Scott C Wesselkamper; Victor Curull; Alba Ramirez-Sarmiento; Albert Sánchez-Font; Judith Garcia-Aymerich; Carlos Coronell; Josep Lloreta; Alvar G Agusti; Joaquim Gea; John A Howington; Michael F Reed; Sandra L Starnes; Nathaniel L Harris; Mark Vitucci; Bryan L Eppert; Gregory T Motz; Kevin Fogel; Dennis W McGraw; Jay W Tichelaar; Mauricio Orozco-Levi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

4.  The feasibility of CT lung volume as a surrogate marker of donor-recipient size matching in lung transplantation.

Authors:  Woo Sang Jung; Seokjin Haam; Jae Min Shin; Kyunghwa Han; Chul Hwan Park; Min Kwang Byun; Yoon Soo Chang; Hyung Jung Kim; Tae Hoon Kim
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

5.  A new functional method to choose the target lobe for lung volume reduction in emphysema - comparison with the conventional densitometric method.

Authors:  Juergen Hetzel; Michael Boeckeler; Marius Horger; Ahmed Ehab; Christopher Kloth; Robert Wagner; Lutz Freitag; Dirk-Jan Slebos; Richard Alexander Lewis; Maik Haentschel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-30

6.  Association Between Emphysema Score, Six-Minute Walk and Cardiopulmonary Exercise Tests in COPD.

Authors:  Li-Fei Chen; Chun-Hua Wang; Pai-Chien Chou; Shu-Chuan Ho; Wen-Ching Joa; Te-Fang Sheng; Han-Pin Kuo
Journal:  Open Respir Med J       Date:  2012-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.